Moxifloxacin Impurity 1 |
|
|---|---|
| CAT. No : | M060119 |
| CAS. No : | 151636-47-4 |
| Mol. F : | C18H26N2O6 |
| Mol. Wt : | 366.41 g/mol |
| Synonyms : | (S,S)-8-Benzyl-2,8-diazabicyclo-[4.3.0]-nonane-D-tartrate |
| Chemical Name : | (4aS,7aS)-6-benzyloctahydro-1H-pyrrolo[3,4-b]pyridine (2S,3S)-2,3-dihydroxysuccinate |
| Stock Status : | Custom Synthesis |
- Buy High-Quality Moxifloxacin Impurity 1 from Simson Pharma Limited at best competitive price.
- Every compound produced by Simson Pharma is accompanied by Certificate of Analysis.
Product Applications & Regulatory Search Terms:
Buy 151636-47-4 | Purchase 151636-47-4 | Order 151636-47-4 | Enquire 151636-47-4 | Price of 151636-47-4 | 151636-47-4 Supplier | 151636-47-4 Manufacturer | 151636-47-4 Exporter | Moxifloxacin Impurity 1 for Method Validation | Moxifloxacin Impurity 1 Reference Standard | Moxifloxacin Impurity 1 for ANDA Filing | Moxifloxacin Impurity 1 for Forced Degradation Studies | Moxifloxacin Impurity 1 Identification Standards | Moxifloxacin Impurity 1 for DMF Filing | Buy high quality Moxifloxacin Impurity 1 | Purchase Moxifloxacin Impurity 1 | Moxifloxacin Impurity 1 suppliers | Moxifloxacin Impurity 1 manufacturers | Moxifloxacin Impurity 1 price | Moxifloxacin Impurity 1 exporter | Order Moxifloxacin Impurity 1 | Enquire Moxifloxacin Impurity 1 | Moxifloxacin Impurity 1 cost | Moxifloxacin Impurity 1 Supplier | Moxifloxacin Impurity 1 Distributor
Related Products
Discover all
![cis-Octahydropyrrolo[3,4-b]pyridine](https://www.simsonpharma.com/admin/uploads/products/m060028.jpg)
Disclaimer:
The information provided on this webpage is based on the best available knowledge at the time of creation. However, accuracy and completeness are not guaranteed. Product specifications may change without notice, and it is the responsibility of the purchaser, user, or importer of record to verify the accuracy and suitability of the product at the time of ordering.
This product is intended for research use only and is not approved for human consumption.
